| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234281 2,3-Dihydrooxadiazoles such as 3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazole and 3-[3-acetyl-5-(2,5-difluorophenyl)-2-phenyl-2,3-dihydro-1,3,4-oxadiazol-2-yl]-N,N-dimethylpropan-1-amine that are useful for treating cancer |
| 09/25/2008 | US20080234276 Heterocyclic Triazines as Hypoxic Selective Protein Kinase Inhibitors |
| 09/25/2008 | US20080234274 Novel Compounds |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234272 Novel Piperazines as Antimalarial Agents |
| 09/25/2008 | US20080234250 Heterocyclic Condensed Compounds Useful as Antidiuretic Agents |
| 09/25/2008 | US20080234247 Heterocyclic analgesic compounds and methods of use thereof |
| 09/24/2008 | EP1971581A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1971580A1 Piperazine compounds with a herbicidal action |
| 09/24/2008 | EP1408986B1 Proteomimetic compounds and methods |
| 09/24/2008 | CN101273048A Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 09/24/2008 | CN101273015A 3-cyclyl-2- (4-sulfamo yl-phenyl) -N-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 09/24/2008 | CN101272789A Melanocortin receptor-specific piperazine compounds with diamine groups |
| 09/24/2008 | CN101272788A Melanocortin receptor-specific piperazine compounds with diamine groups |
| 09/23/2008 | CA2416169C Compositions containing therapeutically active components having enhanced solubility |
| 09/23/2008 | CA2296739C Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them |
| 09/23/2008 | CA2177227C Process for the preparation of optically active piperazine-2-carboxylic acid derivatives |
| 09/18/2008 | WO2008112440A1 Piperazine and piperidine mglur5 potentiators |
| 09/18/2008 | WO2008111473A1 Glucokinase activator |
| 09/18/2008 | WO2008110466A1 Nitroxides for lithium-ion batteries |
| 09/18/2008 | US20080227981 Charge transport compositions and electronic devices made with such compositions |
| 09/18/2008 | US20080227787 4-tert-Butyl-N'-(2-(hydroxyimino)-1-phenylethylidene)benzohydrazide; treatment of inflammation |
| 09/18/2008 | CA2679971A1 Glucokinase activator |
| 09/18/2008 | CA2679526A1 Nitroxides for lithium-ion batteries |
| 09/17/2008 | EP1970373A1 Alicyclic heterocyclic compound |
| 09/17/2008 | EP1968951A1 Novel n-(fluoro-pyrazinyl)-phenylsulfonamid.es as moodulators of chemokine receptor ccr4. |
| 09/17/2008 | CN101268043A Amino-alkyl-amide derivatives as CCR3 receptor ligands |
| 09/16/2008 | US7425557 Inhibitors of glycogen synthase kinase 3 |
| 09/16/2008 | US7425554 1,2-di(cyclic)substituted benzene compounds |
| 09/16/2008 | US7425530 Stereoselective preparation of cyclic L-amino acids |
| 09/12/2008 | WO2008108944A2 Integrated photoactive small molecules and uses thereof |
| 09/12/2008 | WO2008107211A2 Novel p2y12 receptor antagonists |
| 09/11/2008 | US20080221171 neoplastic disease, autoimmune disease, transplantation related pathology and/or degenerative disease; selectively inducing apoptosis in cancer cells |
| 09/11/2008 | US20080221132 Multi-Functional Small Molecules as Anti-Proliferative Agents |
| 09/11/2008 | US20080221123 geranylgeranyltransferase I inhibitors; treatment of neoplasia, hyperproliferative cell growth, psoriasis, intimal hyperplasia (restinosis) and chronic inflammatory diseases including rheumatoid and osteoarthritis |
| 09/11/2008 | US20080221117 Analgesics; antidiabetic agents;anticancer agents;psychological disorders; schizophrenia; neurodegenerative diseases |
| 09/11/2008 | US20080221106 Arylamine Ketones, Their Preparation Methods, The Pharmaceutical Composition Containing Them And Their Use |
| 09/11/2008 | US20080221085 Nicotinic Receptor Agonists for the Treatment of Inflammatory Diseases |
| 09/10/2008 | EP1967513A1 Novel P2Y12 receptor antagonists |
| 09/10/2008 | EP1966187A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases |
| 09/10/2008 | EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 09/10/2008 | EP1966164A1 Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases |
| 09/10/2008 | EP1966132A2 Compounds which modulate the cb2 receptor |
| 09/10/2008 | EP1551902B1 Anisotropic films based on 1,8-naphthoylene-1 ,2 -benzimidazole sulfonates and lyotropic liquid crystal systems and methods for making |
| 09/10/2008 | CN101263126A Quinoxaline derivative, and light emitting element, light emitting device and electronic equipment using the quinoxaline derivative |
| 09/10/2008 | CN100417647C Microwave heating method for synthesizing quinxalines |
| 09/09/2008 | US7423149 Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders |
| 09/09/2008 | US7423147 Therapy of Histamine H3 receptor mediated diseases |
| 09/04/2008 | WO2008106479A2 Poly(1,4-piperazin-2-ones) as rod-like protein- protein interaction inhibitors and their production |
| 09/04/2008 | WO2008042755A3 Inhibitors of cognitive decline |
| 09/04/2008 | US20080214814 Capable of maintaining stability at high temperatures, high pH, under acidic and highly oxidative conditions in the presence of a transition metal; converting methane to methanol; neutralizing nuclear waste treatment; preventing degradation of optical components; metal extraction |
| 09/04/2008 | US20080214573 Compounds Useful for Inhibiting Chk1 |
| 09/04/2008 | US20080214572 Selected Tetracyclic Tetrahydrofuran Derivatives Containing a Cyclic Amine Side Chain |
| 09/04/2008 | US20080210907 Gelling agent, carbon nanotubes aqueous dispersing agent; simple synthesis from low cost, readily available raw materials; rapid elastic modulus recovery; environmentally friendly |
| 09/03/2008 | EP1963346A1 Organometallic complex and light-emitting element, light-emitting device and electronic device using the same |
| 09/03/2008 | EP1963286A1 Pyrazinecarboxamide derivatives and plant disease controlling agents containing the same |
| 09/03/2008 | EP1963285A1 Bradykinin 1 receptor antagonists |
| 09/03/2008 | EP1257541B1 Polypharmacophoric agents |
| 09/03/2008 | CN101255139A Method for synthesizing antitumor compound of diketopiperazine PJ147 |
| 09/02/2008 | US7420089 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 09/02/2008 | US7420055 Antagonists of the chemokine receptor 9 (CCR9); inhibit TECK ligand; antiinflammatory agents and immunoregulators; inflammatory bowel disease; (2-phenylsulfonamidophenyl)-pyridinyl-methanones; N-[4-chloro-2(pyridine4-carbonyl)-phenyl]4-morpholin-4-yl-benzenesulfonamide |
| 09/02/2008 | US7419981 Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor |
| 09/02/2008 | US7419980 Treating conditions improved by monoamine reuptake; 1-[1-(2-naphthyl)-2-piperazin-1-ylethyl]cyclobutanol; sexual disorders, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders, hot flashes |
| 09/02/2008 | US7419967 e.g. hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-3-(cyclopentyloxy)[(3-[2-(dimethylamino)ethyl]aminophenyl)sulfonyl]amino-2-hydroxypropyl)carbamate; against human immunodeficiency virus, chronic and acute viral infections |
| 08/28/2008 | WO2008102713A1 Light-emitting element, light-emitting device, electronic device and quinoxaline derivative |
| 08/28/2008 | WO2008101979A1 Quinoxaline compounds and use thereof |
| 08/28/2008 | US20080207701 Opioid receptor antagonists |
| 08/28/2008 | US20080207639 Moderate binding of selectins ; chronic obstructive pulmonary disease; Crohn's disease; sepsis; antiinflammatory agents; skin disorders; antiarthritic agents; cardiovascular disorders; autoimmune diseases ' |
| 08/28/2008 | US20080207638 Compounds |
| 08/28/2008 | US20080207636 Using a benzmide compound; antidiabetic agents; obesity |
| 08/28/2008 | US20080207630 2-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators |
| 08/28/2008 | US20080207613 Selective Kinase Inhibitors |
| 08/28/2008 | US20080207608 Stroke; antiinflammatory agents; sepsis; allograft; transplant rejection; antitumor agents; liver disorders; brain hemorrage; neurodegenerative diseases ; vision defects |
| 08/28/2008 | US20080206597 Stability; efficiency; hole injection or hole transporting material |
| 08/28/2008 | CA2675884A1 Quinoxaline compounds and use thereof |
| 08/27/2008 | EP1961738A1 New compounds with antiglutamatergic properties and uses thereof |
| 08/27/2008 | EP1960391A1 Piperazine derivatives and their use in therapy |
| 08/27/2008 | EP1960373A2 Novel quinoxaline derivatives and their medical use |
| 08/27/2008 | EP1959946A2 Methods of treating ischemic related conditions |
| 08/27/2008 | EP1638953B1 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 08/27/2008 | EP1368325B1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 08/27/2008 | CN100413859C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing same |
| 08/27/2008 | CN100413850C Chemical compounds |
| 08/26/2008 | US7417145 Process for total synthesis of ecteinascidins and intermediates therefor |
| 08/26/2008 | US7417045 Antiinflammatory agents;to treat chemokine mediated diseases; Antitumor agents; autoimmune diseases |
| 08/26/2008 | US7417044 Tadalafil having a large particle size and a process for preparation thereof |
| 08/26/2008 | US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
| 08/26/2008 | US7417022 Amino acid for deliverying active materials; bioavailability |
| 08/26/2008 | CA2274825C Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase |
| 08/21/2008 | WO2008099874A1 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination |
| 08/21/2008 | WO2008099730A1 Method for production of amine compound using optically active 2-(aroyloxy)propionic acid |
| 08/21/2008 | WO2008099715A1 Method for producing optically active 2-arylpiperazine derivative |
| 08/21/2008 | WO2008098751A1 New compounds with antiglutamatergic properties and uses thereof |
| 08/21/2008 | WO2007045962A3 Novel hdac inhibitors |
| 08/21/2008 | US20080200476 Alaphatic pyrazinoylguanidine sodium channel blockers |
| 08/21/2008 | US20080200473 GABA a receptor; hypnotic agents with a lower risk of side effects; sleep, sedative, muscle relaxant; 4-Dimethylamino-N-(6-methyl-2-p-tolyl-imidazo[1,2-a]pyridin-3-ylmethyl)-benzamide |
| 08/21/2008 | US20080200470 serotonin 5-HT1A receptor agonists; N-heterocyclclediones substituted with a chroman-2-yl, 2-quinolyl, or phenoxy group; 2-[4-[(Chroman-2-yl)methylamino]butyl]-1,3-dioxoperhydroimidazo[1,5-a]pyridine; Parkinson's, cerebral damage by thromboembolitic ictus, depression, migraine, psychosis, urinary disorde |
| 08/21/2008 | US20080200466 Organic Compounds For the Treatment of Inflammatory or Allergic Conditions |
| 08/21/2008 | CA2677905A1 Pharmaceutical composition comprising pyrazine derivatives and neuraminidase inhibitors for treating influenza infections |